Targeting STAT3 has therapeutic potential to regain nilotinib response in parental and resistant chronic myeloid leukemia cells


TEZCANLI KAYMAZ B., SELVİ GÜNEL N., BOZOK ÇETİNTAŞ V., ADAN A., BARAN Y., GÜNDÜZ C., ...More

EACR-Sponsored 3rd Anticancer Agent Development Congress, İzmir, Turkey, 18 - 19 May 2015, pp.182

  • Publication Type: Conference Paper / Full Text
  • City: İzmir
  • Country: Turkey
  • Page Numbers: pp.182
  • Abdullah Gül University Affiliated: Yes